Altre lingue Novavax, Inc.

Azioni

NVAX

US6700024010

Biotecnologia

Tempo reale stimato Cboe BZX Altri mercati azionari 17:01:06 16/12/2025			Variaz. 5gg	Var. 1 gen.
6,375 ^USD	-3,12%		-4,18%	-20,62%

09/12	La FDA indaga se i vaccini Covid possano essere collegati a decessi tra gli adulti - Bloomberg News	RE
01/12	Moderna e altri titoli farmaceutici chiudono in calo dopo che la FDA USA prevede di rafforzare l'approvazione dei vaccini	MT

Altre lingue

Wall Street : Les baisses de taux ne vendent plus du rêve	12/12
Rate Cuts Can't Buy Confidence	12/12
Fda probes if Covid shots might be linked to deaths of adults - Bloomberg News	09/12
Moderna, Other Pharma Stocks Close Lower After US FDA Reportedly Plans to Toughen Vaccine Approval	01/12
MÄRKTE USA/Leichter - Zurückhaltender Start in den Dezember	01/12
USA: recul en bourse des laboratoires sur fond d'incertitudes sur les vaccins	01/12
MÄRKTE USA/Leichte Abgaben - US-Daten nähren Zinssenkungshoffnungen	01/12
USA-Les valeurs à suivre à Wall Street (actualisé)	01/12
Cisco : Alphabet, Cisco, Walt Disney...les valeurs à suivre aujourd'hui à Wall Street	13/11
Novavax : reçoit une lourde charge de l'un de ses actionnaires	13/11
USA-Les valeurs à suivre à Wall Street (actualisé)	13/11
Shah Capital pushes for Novavax sale	12/11
Shah Capital pushes for Novavax sale, warns of proxy fight	12/11
Novavax to Participate in Jefferies London Healthcare Conference	12/11
Novavax delays profitability target with eyes on Sanofi-led launches	06/11
Novavax, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	06/11
Novavax Stock Edges Higher After 2025 Adjusted Revenue Forecast Raised	06/11
Earnings Flash (NVAX) Novavax, Inc. Reports Q3 Revenue $70.4M, vs. FactSet Est of $42.1M	06/11
Earnings Flash (NVAX) Novavax Posts Q3 Net Loss $1.25 a Share, vs. FactSet Est of $1.20 Loss	06/11
Novavax : Q3 Reports & Financials (nvax q3 25 earnings presentation)	06/11
Novavax: Q3 Earnings Snapshot	06/11
Novavax beats quarterly revenue estimates on milestone payment	06/11
Novavax defers profitability target by a year on weak COVID vaccine sales	06/11
Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights	06/11
Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid	04/11

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Trascrizioni Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Ultime notizie

Novavax sale grazie all'accordo sul vaccino di Sanofi da 1,2 miliardi di dollari

10 maggio 2024 alle 19:36